Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia

Gene or cell therapy is currently not fully efficacious for arteriosclerosis obliterans (ASO). In this study, we determined whether YS-1402, a slow-release synthetic prostacyclin agonist, promoted neovascularization and skeletal muscle regeneration in a mouse model of critical limb ischemia (CLI). W...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Takaya, Miyagawa, Shigeru, Shibuya, Takashi, Sakai, Yoshiki, Harada, Akima, Watanabe, Kenichi, Sawa, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321796/
https://www.ncbi.nlm.nih.gov/pubmed/32637444
http://dx.doi.org/10.1016/j.omtm.2020.05.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321796/
https://www.ncbi.nlm.nih.gov/pubmed/32637444
http://dx.doi.org/10.1016/j.omtm.2020.05.022

Ejemplares similares